Understanding the growing demand for genetic screening in the community, Eurofins GENTIS has developed five hereditary cancer testing packages ranging from basic to advanced levels, tailored to different individuals, age groups, and family histories.
Why consider hereditary cancer testing?
Unlike conventional tests that detect cancer after it develops, hereditary cancer testing focuses on genetic analysis to determine cancer risk before clinical symptoms appear.
Key benefits include:
- Early detection of potential hereditary cancer risks
- Proactive development of personalized screening plans
- Support for physicians in prevention and treatment counseling
- Provision of valuable genetic information for family members
- Reduced psychological burden through better understanding of personal health risks
With internationally standardized laboratories and an experienced team of genetic experts, Eurofins GENTIS delivers accurate, reliable testing solutions tailored to the Vietnamese population.
Summary of 5 hereditary cancer testing packages at Eurofins GENTIS
LADY - CARE: Hereditary cancer testing package for women
LADY - CARE is specifically designed for women, focusing on cancers with high incidence rates and strong hereditary associations.
- Analysis of 10 genes
- Screening for hereditary breast cancer, ovarian cancer, and colorectal cancer
Suitable for:
- Women with a family history of breast, ovarian, or colorectal cancer
- Women who wish to proactively assess hereditary cancer risk
- Women of reproductive or middle age
LADY - CARE helps women better understand their genetic risks and develop appropriate medical monitoring and intervention plans to enhance quality of life.
MEN - CARE: Hereditary cancer screening solution for Men
Men also face various cancers influenced by hereditary factors, particularly prostate and gastrointestinal cancers.
- Analysis of 10 genes
- Screening for hereditary prostate cancer, colorectal cancer, and gastric cancer
Suitable for:
- Men with a family history of related cancers
- Middle-aged men or those with high-risk lifestyles or environmental exposures
- Individuals seeking proactive genetic health screening
MEN - CARE is an important step in early cancer risk detection, enabling long-term prevention and medical follow-up.
PRE - CARE: Expanded screening for 15 hereditary cancers
PRE - CARE is an extended hereditary cancer testing package for individuals seeking more comprehensive risk assessment.
- Analysis of mutations in 17 genes
- Screening for 15 hereditary cancers, including: lung, stomach, breast, ovarian, colorectal, pancreatic, kidney, prostate, thyroid, skin, endometrial cancers, paraganglioma, retinoblastoma, pheochromocytoma, and multiple endocrine neoplasia
Suitable for:
- Individuals with family histories of multiple cancer types
- Those seeking expanded hereditary cancer screening
- Individuals planning marriage or childbirth
PRO - CARE: Advanced hereditary cancer testing package
PRO - CARE provides a comprehensive overview of hereditary cancer risks.
- Analysis of mutations in 133 genes
- Screening for 30 hereditary cancers, including: lung, stomach, breast, ovarian, colorectal, pancreatic, kidney, prostate, thyroid, skin, endometrial, liver, bladder, head and neck, esophageal, biliary tract, small intestine, brain, bone, parathyroid cancers; acute leukemia (blood cancer); rhabdomyosarcoma; pituitary adenoma; neuroblastoma; neurofibroma; and multiple myeloma
Suitable for:
- Individuals at high risk of cancer
- Families with multiple affected members
- Those requiring comprehensive genetic evaluation for long-term monitoring
DIAMOND - CARE: The most comprehensive genetic testing package
DIAMOND - CARE is the most advanced and comprehensive package at Eurofins GENTIS, combining hereditary cancer screening with inherited chronic disease testing.
- Total analysis of 177 genes associated with 69 hereditary chronic diseases and cancers, including:
- 10 genes – 9 common autosomal recessive disorders:
Alpha Thalassemia, Beta Thalassemia, G6PD deficiency, Phenylketonuria (PKU), Galactose metabolism disorder, Citrin deficiency–related cholestasis, 5-Alpha Reductase deficiency–related male sex development disorder, Pompe disease, Wilson disease - 133 genes – Screening for 30 hereditary cancers (entire PRO - CARE panel)
- 34 genes – 30 hereditary syndromes and chronic conditions:
20 cardiovascular diseases, 5 connective tissue disorders, and 5 endocrine–metabolic disorders
DIAMOND - CARE is especially suitable for individuals seeking a comprehensive evaluation of hereditary health risks for themselves and their families.
With advanced gene sequencing technology, strict quality control processes, and a highly experienced team of experts, Eurofins GENTIS is committed to delivering accurate, reliable, and clinically valuable results.
Hereditary cancer testing is not just a test — it is a proactive step toward early prevention, appropriate monitoring, and personalized healthcare.
Contact Eurofins GENTIS via hotline 1800 2010 for detailed consultation and to choose the most suitable testing package for you and your family.
